Sigismundus W W Lubsen Net Worth

The estimated Net Worth of Sigismundus W W Lubsen is at least $3.66 Миллион dollars as of 23 February 2015. Sigismundus Lubsen owns over 2,000 units of Teleflex stock worth over $3,663,793 and over the last 21 years Sigismundus sold TFX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Sigismundus Lubsen TFX stock SEC Form 4 insiders trading

Sigismundus has made over 1 trades of the Teleflex stock since 2015, according to the Form 4 filled with the SEC. Most recently Sigismundus exercised 2,000 units of TFX stock worth $105,000 on 23 February 2015.

The largest trade Sigismundus's ever made was exercising 2,000 units of Teleflex stock on 23 February 2015 worth over $105,000. On average, Sigismundus trades about 63 units every 0 days since 2004. As of 23 February 2015 Sigismundus still owns at least 14,983 units of Teleflex stock.

You can see the complete history of Sigismundus Lubsen stock trades at the bottom of the page.

What's Sigismundus Lubsen's mailing address?

Sigismundus's mailing address filed with the SEC is 610 LINDSAY CIRCLE, , VILLANOVA, PA, 19085.

Insiders trading at Teleflex

Over the last 21 years, insiders at Teleflex have traded over $16,880,558 worth of Teleflex stock and bought 4,250 units worth $1,104,860 . The most active insiders traders include Gretchen R Haggerty, W Kim Foster и Benson Smith. On average, Teleflex executives and independent directors trade stock every 22 days with the average trade being worth of $1,065,906. The most recent stock trade was executed by Stuart A Randle on 16 August 2024, trading 2,674 units of TFX stock currently worth $323,554.

What does Teleflex do?

teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. headquartered in wayne, pa, teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 150 countries.

Complete history of Sigismundus Lubsen stock trades at Teleflex

Teleflex executives and stock owners

Teleflex executives and other stock owners filed with the SEC include:

• Liam Kelly,
  Chairman of the Board, President, Chief Executive Officer
• Thomas Powell,
  Chief Financial Officer, Executive Vice President
• Liam J. Kelly,
  Chairman, Pres & CEO
• James Leyden,
  Corporate Vice President, General Counsel, Secretary
• Cameron Hicks,
  Corporate Vice President - Human Resources and Communications
• Thomas E. Powell,
  Exec. VP & CFO
• Karen Boylan,
  Vice President - Global Strategic Projects
• James P. Winters,
  Corp. VP, Manufacturing and Supply Chain
• Cameron P. Hicks,
  Corp. VP & Chief HR Officer
• John Heinmiller,
  Independent Director
• George Babich,
  Lead Independent Director
• Candace Duncan,
  Independent Director
• Stuart Randle,
  Independent Director
• Andrew Krakauer,
  Independent Director
• Gretchen Haggerty,
  Independent Director
• Stephen Klasko,
  Independent Director
• Richard Packer,
  Independent Director
• James Winters,
  Corporate Vice President - Manufacturing and Supply Chain
• Mario Wijker,
  Corporate Vice President - QA/RA
• Jake Elguicze,
  Treasurer and Vice President Investor Relations
• James Ferguson,
  Pres & GM of Surgical
• Howard Cyr,
  Corp. VP & Chief Compliance Officer
• Daniel V. Logue,
  Corp. VP, Gen. Counsel & Sec.
• John Hsu C.F.A.,
  VP of Investor Relations
• Timothy F. Duffy,
  VP & Chief Information Officer
• John R. Deren,
  Corp. VP & Chief Accounting Officer
• W Kim Foster,
  Director
• Thomas Anthony Kennedy,
  Senior VP, Global Operations
• Patricia C Barron,
  Director
• Jeffrey A Graves,
  Director
• William Roland Cook,
  Director
• Benson Smith,
  Director
• Richard A Meier,
  Exec. Vice Pres. and CFO
• James W Zug,
  Director
• Charles Edward Williams,
  Corp. Controller and CAO
• John B Suddarth,
  President-Aerospace
• Jeffrey P Black,
  President, CEO
• Vincent Northfield,
  President - Commercial
• R Ernest Waaser,
  President - Medical
• Harold L Iii Yoh,
  Director
• Sigismundus W W Lubsen,
  Director
• Seldeneck Judith M Von,
  Director
• Matthew J Jennings,
  Sr. VP, Corp. Development
• Kevin K Gordon,
  Vice Pres. Corporate
• Julie Mcdowell,
  Sr. VP Corp. Communic.
• John J Sickler,
  Vice Chairman
• Randall P Gaboriault,
  Sr. Vice Pres. & Chf Info Off
• Laurence G Miller,
  Sr.VP, General
• Forrest R Whittaker,
  President - Medical
• James W Eug,
  Director
• Steven Kent Chance,
  Vice Pres., General
• James W Stratton,
  Director
• Clark D Handy,
  Exec.Vice Pres.
• Martin S Headley,
  Exec. Vice Pres.
• Lennox K Black,
  Non-Executive
• James V Agnello,
  Corporate Controller
• Donald Beckman,
  Director
• Joan W Schwartz,
  Assoc.Gen'l Counsel
• Thomas M Byrne,
  Assistant Treasurer
• Joseph S Gonnella,
  Director
• C Jeffrey Jacobs,
  Treasurer
• Harold L Jr Zuber,
  Exec. Vice Pres. and
• Janine Dusossoit,
  
• Jaewon Ryu,
  Director
• Jay White,
  CVP & Pres, Global Commercial
• John Deren,
  Corp. VP & CAO
• Daniel V. Logue,
  CVP, General Counsel & Secty
• Neena M Patil,
  Director